Sale of new drug for osteoporosis approved

Published: 2012-03-22 06:59:00
Updated: 2012-03-22 06:59:00
A newly-developed drug for osteoporosis has received approval for production and sale from the health authorities.

Layla tablets, developed by PMG Korea, has passed safety and effectiveness tests, becoming the seven new natural drug developed by a local pharmaceutical company, the Korea Food &...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.